Literature DB >> 10630259

Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.

K H Antman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630259

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.

Authors:  P H Cottu; J M Extra; M Espie; J P Marolleau; A de Roquancourt; J Makke; J M Miclea; V Laurence; D Mayeur; F Lerebours; C Cuvier; M Marty
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.